SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-17-148142
Filing Date
2017-04-28
Accepted
2017-04-28 16:09:04
Documents
5
Effectiveness Date
2017-04-28

Document Format Files

Seq Description Document Type Size
1 DEFA14A d373010ddefa14a.htm DEFA14A 26405
2 GRAPHIC g373010naapg001.jpg GRAPHIC 151552
3 GRAPHIC g373010naapg002.jpg GRAPHIC 210897
4 GRAPHIC g373010naapg003.jpg GRAPHIC 77355
5 GRAPHIC g373010naapg004.jpg GRAPHIC 67241
  Complete submission text file 0001193125-17-148142.txt   714337
Mailing Address 10614 SCIENCE CENTER DRIVE SAN DIEGO CA 92121
Business Address 10614 SCIENCE CENTER DRIVE SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Filer) CIK: 0001505512 (see all company filings)

IRS No.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-35670 | Film No.: 17795528
SIC: 2834 Pharmaceutical Preparations